Global NGS Based Diagnostics Market Size, Status and Forecast 2020-2026

Next generation sequencing (NGS) based diagnostics are the medical devices used for diagnosis of various conditions using advanced generation sequencing platforms.
North America is currently leading the market due to the research and innovations and presence of maximum numbers of players. Europe is following America. Rising caseload of cancer, incidence of drug-resistant infectious diseases in Asian and African countries have created a huge demand of such technologies. Hence, market will grow at a fast pace in these regions.
Market Analysis and Insights: Global NGS Based Diagnostics Market
In 2019, the global NGS Based Diagnostics market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global NGS Based Diagnostics Scope and Market Size
NGS Based Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global NGS Based Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the NGS Based Diagnostics market is segmented into DNA Sequencing, RNA Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Other, etc.
Segment by Application, the NGS Based Diagnostics market is segmented into Hospitals, Clinics, Academics/Research Institutions, etc.
Regional and Country-level Analysis
The NGS Based Diagnostics market is analysed and market size information is provided by regions (countries).
The key regions covered in the NGS Based Diagnostics market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and NGS Based Diagnostics Market Share Analysis
NGS Based Diagnostics market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in NGS Based Diagnostics business, the date to enter into the NGS Based Diagnostics market, NGS Based Diagnostics product introduction, recent developments, etc.
The major vendors include Janssen, Roche, Qiagen, ThermoFisher Scientific, Oxford Gene Technology, Illumina, Pacific Biosciences, Paradigm Diagnostics, Innogene Kalbiotech, Admera Health, AITbiotech, Centogene, Phalanx Biotech Group, iGenomX, etc.

This report focuses on the global NGS Based Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the NGS Based Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Janssen
Roche
Qiagen
ThermoFisher Scientific
Oxford Gene Technology
Illumina
Pacific Biosciences
Paradigm Diagnostics
Innogene Kalbiotech
Admera Health
AITbiotech
Centogene
Phalanx Biotech Group
iGenomX

Market segment by Type, the product can be split into

DNA Sequencing
RNA Sequencing
Whole Genome Sequencing
Whole Exome Sequencing
Other

Market segment by Application, split into

Hospitals
Clinics
Academics/Research Institutions

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global NGS Based Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the NGS Based Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of NGS Based Diagnostics are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.